Mirazid shows insignificant activity against ovine fascioliasis

Annals of Tropical Medicine and Parasitology

Volumn 103, Issue 7, 2009, Pages 605-616

  Botros, S S ^a   El Lakkany, N M ^a   Badawy, A A ^b   Mahmoud, S S ^a   Ebeid, F A ^a   Fenwick, A ^c  

^a Giza   (Egypt)

^b Theodor Bilharz Research Institute   (Egypt)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; FASCIOLICIDE; GAMMA GLUTAMYLTRANSFERASE; MIRAZID; PLANT EXTRACT; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHELMINTIC ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; COMMIPHORA; CONTROLLED STUDY; EGYPT; FASCIOLA; FASCIOLIASIS; FECES ANALYSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; LIVER; METACERCARIA; NONHUMAN; SHEEP DISEASE; SINGLE DRUG DOSE;

ANIMALS; ANTHELMINTICS; FASCIOLIASIS; LIVER; PARASITE EGG COUNT; PHYTOTHERAPY; PLANT EXTRACTS; SHEEP; SHEEP DISEASES;

ANIMALIA; COMMIPHORA; FASCIOLA; OVIS; OVIS ARIES;

EID: 73449091861     PISSN: 00034983     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/000349809X12459740922453     Document Type: Article

References (58)

1. Abo-Madyan, A. A., Morsy, T. A. & Motawea, S. M. (2004a). Efficacy of myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia center, El-Fayoum governorate, Egypt. Journal of the Egyptian Society of Parasitology, 34, 423-446.
2. Abo-Madyan, A. A., Morsy, T. A., Motawea, S. M. & Morsy, A. T. (2004b). Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia center), Al-Fayoum governorate. Journal of the Egyptian Society of Parasitology, 34, 807-818.
3. Anderson, P. H., Berrett, S., Brush, P. J., Hebert, C. N., Parfitt, J. W. & Patterson, D. S. (1977). Biochemical indicators of liver injury in calves with experimental fascioliasis. Veterinary Record, 100, 43-45.
4. Anon. (2002). Problems with dietary supplements. Medical Letters, 44, 48-86.
5. Apt, W., Aguilera, X., Vega, F., Miranda, C., Zulantay, I., Perez, C., Gabor, M. & Apt, P. (1995). Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. American Journal of Tropical Medicine and Hygiene, 52, 532-535.
6. Badria, F., Abou-Mohamed, G., El-Mowafy, A., Massoud, A. & Salama, O. (2001). Mirazid: a new schistosomidal drug. Pharmaceutical Biology, 93, 127-131.
7. Barakat, R., El-Morshedy, H. & Fenwick, A. (2005). Efficacy of myrrh in the treatment of human schistosomiasis mansoni. American Journal of Tropical Medicine and Hygiene, 73, 365-367.
8. Benchaoui, H. A. & McKellar, Q. A. (1993). Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica. Xenobiotica, 23, 439-448.
9. Boray, J. C., Crowfoot, P. D., Strong, M. B., Allison, J. R., Schellenbaum, M., Von Orelli, M. & Sarasin, G. (1983). Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Record, 113, 315-317.
10. Botros, S., William, S., Ebeid, F., Cioli, D., Katz, N., Day, T. A. & Bennett, J. L. (2004). Lack of evidence an antischistosomal activity of myrrh in experimental animals. American Journal of Tropical Medicine and Hygiene, 71, 206-210.
11. Botros, S., El-Sayed, H., El-Dusoki, H., Sabry, H., Rabie, I., El-Ghannam, M., Hassanein, M., El-Wahab, Y. A. & Engels, D. (2005). Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma-infected school children and households. American Journal of Tropical Medicine and Hygiene, 72, 119-123.
12. Bulgin, M. S., Anderson, B. C., Hall, R. F. & Lang, B. Z. (1984). Serum gamma glutamyl transpeptidase activity in cattle with induced fasciolosis. Research in Veterinary Science, 37, 167-171.
13. Cheever, A. W. (1968). Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bulletin of the World Health Organization, 39, 328-331.
14. Doumas, B. T., Watson, W. R. & Biggs, H. G. (1971). Albumin standard and measurement of serum albumin with Bromocresol Green. Clinica Chimica Acta, 31, 87-96.
15. Ebeid, F., El-Lakkany. N., Seif El-Din, S., Sabra, A., Noseir, M. & Botros, S. (2005a). Effect of Mirazid against different developmental stages of Schistosoma mansoni worms and its safety in normal mice. Egyptian Journal of Schistosomiasis and Infectious Endemic Diseases, 27, 15-24.
16. Ebeid, F. A., Mahmoud, S. S., Botros, S. S. & Badawy, A. A. (2005b). Evaluation of the antibilharzial activity of mirazid versus praziquantel against S. haematobium: an experimental study. Egyptian Journal of Schistosomiasis and Infectious Endemic Diseases, 27, 25-37.
17. El-Mathal, E. M. & Fouad, M. A. (2005). Human fascioliasis among immigrant workers in Saudi Arabia. Journal of the Egyptian Society of Parasitology, 35, 1199-1207.
18. El Ridi, R., Salah, M., Wagih, A., William, H., Tallima, H., El Shafie, M. H., Abdel Khalek, T., El Amir, A., Abo Ammou, F. F. & Motawi, H. (2007). Fasciola gigantica excretory-secretory products for immunodiagnosis and prevention of sheep fasciolosis. Veterinary Parasitology, 149, 219-228.
19. Gajewska, A., Smaga-Kozłowska, K. & Wiśniewski, M. (2005). Pathological changes of liver in infection of Fasciola hepatica. Wiadomości Parazytologiczne, 51, 115-123.
20. Galtier, P., Larrieu, G., Tufenkji, A. E. & Franc, M. (1986). Incidence of experimental fasciolosis on the activity of drug-metabolizing enzymes in lamb liver. Drug Metabolism and Disposition, 14, 137-141.
21. Greene, D. A. (1993). Gold, frankincense, myrrh and medicine. North Carolina Medical Journal, 54, 620-622.
22. Guirgis, F. R. & Mahmoud, S. S. (2003). On the efficacy of a new antischistosomal drug (Mirazid) against Schistosoma haematobium and S. mansoni: an in vivo study. Journal of the Egyptian and German Societies of Zoology, 42, 89-98.
23. Haridy, F. M., El-Sherbiny, G. T. & Morsy, T. A. (2006). Some parasitic flukes infecting farm animals in Al-Santa center, Gharbia governorate, Egypt. Journal of the Egyptian Society of Parasitology, 36, 259-264.
24. Hassan, M. M., Abbaza, B. E., El-Karamany, I., Dvab, A. K., El-Sharkawy, E. M., Ismail, F. & Asal, K. H. (2004). Detection of anti-Fasciola isotypes among patients with fascioliasis before and after treatment with Mirazid. Journal of the Egyptian Society of Parasitology, 34, 857-864.
25. Hien, T. T., Truong, N. T., Minh, N. H., Dat, H. D., Dung, N. T., Hue, N. T., Dung, T. K., Tuan, P. Q., Campbell, J. I., Farrar, J. J. & Day, J. N. (2008). A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. American Journal of Tropical Medicine and Hygiene, 78, 388-392.
26. Katz, N. Z., Coelho, P. M. Z. & Pellegrino, J. (1970). Evaluation of Kato quantitative method through the recovery of Schistosoma mansoni eggs added to human faeces. Parasitology, 56, 1032-1033.
27. Keiser, J. & Morson, G. (2008). Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. Experimental Parasitology, 118, 228-237.
28. Keiser, J. & Utzinger, J. (2005). Emerging foodborne trematodiasis. Emerging Infectious Diseases, 11, 1507-1514.
29. Keiser, J., Utzinger, J., Vennerstrom, J. L., Dong, Y., Brennan, G. & Fairweather, I. (2007). Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 1219-1222.
30. Kind, P. & King, E. J. (1954). Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. Journal of Clinical Pathology, 7, 322.
31. Maher, K., El Ridi, R., Nour Elhoda, A., El-Ghannam, M., Shaheen, H., Shaker, Z. & Hassanein, H. I. (1999). Parasite-specific antibody profile in human fascioliasis: application for immunodiagnosis of infection. American Journal of Tropical Medicine and Hygiene, 61, 738-742
32. Martínez-Moreno, A., Martínez-Moreno, F. J., Acosta, I., Gutiérrez, P. N., Becerra, C. & Hernández, S. (1997). Humoral and cellular immune responses to experimental Fasciola hepatica infections in goats. Parasitology Research, 83, 680-686.
33. Martínez-Moreno, A., Jiménez-Luque, V., Moreno, T., Redondo, E. S. H., de las Mulas, J. M. & Pérez, J. (1999). Liver pathology and immune response in experimental Fasciola hepatica infections of goats. Veterinary Parasitology, 82, 19-33.
34. Mas-Coma, S. (2005). Epidemiology of fascioliasis in human endemic areas. Journal of Helminthology, 79, 207-216.
35. Mas-Coma, S., Bargues, M. D. & Esteban, J. G. (1999). Human fasciolosis. In Fasciolosis, ed. Dalton, J. P. pp. 411-434. Wallingford, U.K.: CABI Publishing.
36. Massoud, A., El-Sisi, S., Salama, O. & Massoud, A. (2001). Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). American Journal of Tropical Medicine and Hygiene, 65, 96-99.
37. McConville, M., Brennan, G. P., Flanagan, A., Edgar, H. W. J., McCoy, M., Castillo, R., Hernandez-Campos, A. & Fairweather, I. (2008). Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Veterinary Parasitology, 153, 52-64.
38. McManus, D. P. & Dalton, J. P. (2006). Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology, 133 (Suppl.), S43-S61.
39. Michie, C. A. & Cooper, E. (1991). Frankincense and myrrh as remedies in children. Journal of the Royal Society of Medicine, 84, 602-605.
40. Moran, J., Addy, M. & Roberts, S. (1992). A comparison of natural product, triclosan and chlorhexidine mouthrinses on 4-day plaque regrowth. Journal of Clinical Periodontology, 19, 578-582.
41. Morsy, T. A., Salem, H. S., Haridy, F. M., Riffat, M. M., Abo-Zenadah, N. Y. & El-Kadi, A. M. (2005). Farm animals' fascioliasis in Ezbet El-Bakly (Tamyia center), Al-Fayoum governorate. Journal of the Egyptian Society of Parasitology, 35, 825-832.
42. Persijn, J. & van der Slik, W. (1976). A new method for the determination of gamma glutamyl transferase in serum. Journal of Clinical Chemistry and Clinical Biochemistry, 14, 421-427.
43. Phiri, I. K., Phiri, A. M. & Harrison, L. J. S. (2007). The serum glucose and b-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection. Veterinary Parasitology, 143, 287-293.
44. Raadsma, H. W., Kingsford, N. M., Suharyanta Spithill, T. W. & Piedrafita, D. (2007). Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep: I. Comparative immunological and plasma biochemical changes during early infection. Veterinary Parasitology, 143, 275-286.
45. Rapic, D., Dzakula, N., Sakar, D. & Richards, R. J. (1988). Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle. Veterinary Record, 122, 59-62.
46. Reitman, S. & Frankel, S. (1957). A colourimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28, 56-63.
47. Richards, R. J., Bowens, F. L., Essenwein, F., Steiger, R. F. & Biischer, G. (1990). The efficacy of triclabendazole and other anthelmintics against Fasciola hepatica in controlled studies in cattle. Veterinary Record, 126, 213-216.
48. Sandemen, R. M. & Howell, M. J. (1981). Response of sheep to challenge infection with Fasciola hepatica. Research in Veterinary Science, 30, 294-297.
49. Sheir, Z., Naser, A. A., Massoud, A., Salama, O., Badra, G. A., El-Shennawy, H., Hassan, N. & Hammad, S. M. (2001). A safe, effective, herbal anti-schistosomal therapy derived from myrrh. American Journal of Tropical Medicine and Hygiene, 65, 700-704.
50. Smeal, M. G. & Hall, C. A. (1983). The activity of triclabendazole against immature and adult Fasciola hepatica infections in sheep. Australian Veterinary Journal, 60, 329-331.
51. Soliman, O. E., El-Arman, M., Abdul-Samie, E. R., El-Nemr, H. I. & Massoud, A. (2004). Evaluation of myrrh (Mirazid) therapy in fascioliasis and intestinal schistosomiasis in children: immunological and parasitological study. Journal of the Egyptian Society of Parasitology, 34, 941-966.
52. Suhardono, Roberts, J. A. & Copeman, D. B. (2006). Optimization of the procedure for counting the eggs of Fasciola gigantica in bovine faeces. Tropical Animal Health and Production, 38, 383-387.
53. Thienpont, D., Rochette, F. & Vanparijs, O. F. J. (1979). Diagnosing Helminthiasis Through Coprological Examination. Beerse, Belgium: Janssen Research Foundation.
54. Turner, K., Armour, J. & Richards, R. J. (1984). Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep. Veterinary Record, 114, 41-42.
55. Weichselbaum, P. E. (1946). An accurate and rapid method for determination of protein in small amounts of blood serum and plasma. American Journal of Tropical and Clinical Pathology, 16, 40.
56. Weigl, E., Bach, H. & Krieg, D (1975). Serum bilirubin in an obvious healthy population. Medizinische Klinik, 70, 664-669.
57. Wolff, K., Eckert, J., Schneiter, G. & Lutz, H. (1983). Efficacy of triclabendazole against Fasciola hepatica in sheep and goats. Veterinary Parasitology, 13, 145-150.
58. Wood, I. B., Amaral, N. K., Bairden, K., Duncan, J. L., Kassi, T., Malone, J. B., Jr, Pankavich, J. A., Reinecke, R. K., Slocombe, O., Taylor, S. M. & Vercruysse, J. (1995). World Association for the Advancement of Veterinary Parasitology (WAAVP) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine). Veterinary Parasitology, 58, 181-213.